Certified by Founder Lodge
Digitalis Ventures
United States - New York, NY
INVESTOR
1 Disclosed Funding Rounds $100,000,000
12 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Digitalis Ventures is a venture capital firm that invests in solutions to complex problems in human and animal health. Digitalis partners with entrepreneurs, scientists, and inventors across
| Company | Date | Round | Raised |
|---|---|---|---|
 Matchpoint Therapeutics |
October, 17 ,2022 | Series A | $100,000,000 |
 Eden Brew |
May, 31 ,2022 | Unknown | $5,000,000 |
 Ness |
May, 11 ,2022 | Seed | $15,500,000 |
 Switch Therapeutics |
March, 15 ,2023 | Series A | $52,000,000 |
 Companion |
April, 13 ,2023 | Unknown | $6,000,000 |
 Ascend Gene & Cell Therapies |
May, 10 ,2023 | Series A | $132,500,000 |
 T-Therapeutics Ltd |
November, 16 ,2023 | Series A | $59,707,000 |
 Gallant Therapeutics |
January, 09 ,2024 | Series A | $15,000,000 |
 Ansel Health |
January, 24 ,2024 | Unknown | $20,000,000 |
 MoeGo |
March, 05 ,2024 | Series A | $24,000,000 |
 Alterome Therapeutics, Inc |
April, 09 ,2024 | Series B | $132,000,000 |
 ELEGEN |
May, 16 ,2024 | Series B | $35,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
OTPLESS | $3,500,000 | (May 17, 2024)
Watershed Health | $13,600,000 | (May 17, 2024)
Aeropay | $20,000,000 | (May 17, 2024)
c/side | $1,700,000 | (May 17, 2024)
SINE Digital | $2,500,000 | (May 17, 2024)
